Manufacturing & Production

JRS Pharma is planning a 9,200-square-foot expansion of its manufacturing facility, including related site improvements, machinery, and equipment. The project comprises an $18 million capital investment which will result in the creation of 18 new jobs, all of which will meet the state’s current High Quality Jobs wage threshold of $24.40 per hour.

JRS Pharma will receive a ten-year, declining scale tax exemption on new property value generated by the project, in accordance with the Urban Revitalisation Plan for the area. The incentive will provide an estimated exemption of $462,000 in total property taxes over the ten year period.

JRS is a manufacturer of excipients (inactive substances that serve as the vehicle or medium for a drug or other active sbstance) for the global health science industry. The company’s products include high functionality excipients, binders, disintegrants, lubricants, functional fillers, thickeners, stabilisers, carriers, and coatings.